Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-26 @ 3:20 PM
NCT ID: NCT07458620
Eligibility Criteria: Inclusion Criteria: * Diagnosis of Alzheimer's Disease: Participants must have a confirmed diagnosis of Alzheimer's Disease as evaluated by a neurologist and a psychiatrist at the hospital. * Positive Amyloid-PET Scan: The result of a \[18F\] Florbetapir (Amyloid-PET) scan must be positive, indicating the presence of amyloid plaques in the brain. * Willingness to Consent: Participants or their legal representatives must be willing to sign a written informed consent form. * Participants must be adults aged 18 years or older Exclusion Criteria: * Lack of Informed Consent: Potential participants are excluded if they are unable to exercise autonomy and informed consent cannot be obtained from a legal representative or authorized person. * Prior Surgical History: Individuals who have previously undergone neck lymphatic dissection, nasopharyngeal surgery, or intracranial surgery are excluded. * Concurrent Medical Conditions: The trial excludes persons with thyroid disease or chronic heart failure. * Specific Allergies: Candidates with a history of allergies to shellfish or iodine are excluded due to the use of Indocyanine Green (ICG) during the procedure. * Unresolved Concerns: Anyone who has doubts about the trial and cannot receive satisfactory answers is excluded. * Anesthesia Risks: Individuals deemed medically unfit for general anesthesia-for example, those with severe cardiopulmonary insufficiency or a history of specific anesthetic drug allergies-are ineligible.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT07458620
Study Brief:
Protocol Section: NCT07458620